Production (Stage)
U
Belite Bio, Inc BLTE
$61.61 -$0.02-0.03% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 03/31/2024 12/31/2023 09/30/2023 06/30/2023
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
SG&A Expenses -- 7.23M 6.82M 6.23M --
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses -- 33.12M 31.67M 31.43M --
Operating Income -- -33.12M -31.67M -31.43M --
Income Before Tax -- -32.60M -31.62M -31.42M --
Income Tax Expenses -- 9.00K 9.00K 10.00K --
Earnings from Continuing Operations -- -32.61 -31.63 -31.43 --
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -- -32.61M -31.63M -31.43M --
EBIT -- -33.12M -31.67M -31.43M --
EBITDA -- -33.01M -31.59M -31.37M --
EPS Basic -- -1.18 -1.24 -1.27 --
Normalized Basic EPS -- -0.15 -0.15 -0.17 --
EPS Diluted -- -1.18 -1.24 -1.27 --
Normalized Diluted EPS -- -0.15 -0.15 -0.17 --
Average Basic Shares Outstanding -- 111.09M 102.37M 98.99M --
Average Diluted Shares Outstanding -- 111.09M 102.37M 98.99M --
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --